+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Choroideremia Treatment Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Treatment Type, Distribution Channel, Route of Administration, Region, By Country: 2020-2030

  • PDF Icon

    Report

  • 325 Pages
  • May 2024
  • Region: Global
  • Azoth Analytics
  • ID: 5971375
Description Jump to:
This report highlights different factors and opportunities prevailing in the “Global Choroideremia Treatment Market (2024 Edition)”. According to the report, Global Choroideremia Treatment Market valued at USD 9.33 Billion in 2023 is expected to grow at a CAGR of 6.2% during 2025-2030.

The report explores a multi-faceted opportunity landscape in terms of market segmentation by Treatment Type (Gene Therapy, Topical Carbonic Inhibitor, Dorzolamide, Lutein and Luxturna), by Distribution Channel (Online Pharmacies, Hospital Pharmacies, Retail Pharmacies and Drugstores) and by Route of Administration (Oral & Intravenous and Ophthalmic).

Market Overview

The Choroideremia treatment market is experiencing significant growth, driven by advancements in medical research and an increasing understanding of this rare genetic disorder. Choroideremia, an inherited retinal disease primarily affecting males, leads to progressive vision loss and eventual blindness due to the degeneration of the choroid, retinal pigment epithelium (RPE), and photoreceptors. The market's expansion is fueled by the development of innovative therapies, particularly gene therapies, which offer promising prospects for altering the disease's progression and improving patients' quality of life.

Choroideremia is caused by mutations in the CHM gene, which encodes the Rab escort protein-1 (REP-1). This protein is essential for intracellular trafficking, and its absence disrupts cellular functions, leading to cell death in the retinal layers. The disorder's pathophysiology and genetic basis have been well-characterized, paving the way for targeted therapeutic interventions. The primary aim of current treatment strategies is to halt or slow down the degeneration process, thereby preserving vision for as long as possible.

Gene therapy has emerged as a revolutionary approach in the Choroideremia treatment market. This technique involves delivering a functional copy of the CHM gene to the affected cells in the retina. By doing so, it aims to restore the production of REP-1 protein, thereby preventing further degeneration. One of the most advanced candidates in this domain is the gene therapy product BIIB111 (formerly known as NSR-REP1) developed by Biogen. Clinical trials have shown that BIIB111 can be safely administered and has the potential to stabilize or improve visual function in patients with Choroideremia.

Another notable player in the gene therapy space is 4D Molecular Therapeutics, which is developing 4D-110, a gene therapy designed to deliver the CHM gene using a novel adeno-associated virus (AAV) vector. This therapy is currently undergoing clinical trials, and early results have demonstrated its safety and efficacy in delivering the therapeutic gene to the retina. The use of AAV vectors is particularly advantageous due to their ability to target retinal cells effectively and their established safety profile.

Apart from gene therapy, other therapeutic approaches are also being explored. For instance, retinal implants and prosthetics, like those developed by Retina Implant AG, offer an alternative for patients in advanced stages of the disease. These devices can potentially restore partial vision by electronically stimulating the remaining functional retinal cells. Although still in the experimental stage, these technologies represent a crucial area of research and development in the Choroideremia treatment market.

The market dynamics are also influenced by several key players investing in research and development. Companies such as Novartis AG, Spark Therapeutics, Inc., bluebird bio, Inc., and Copernicus Therapeutics, Inc. are at the forefront of these efforts. Their extensive R&D pipelines include various gene therapy candidates at different stages of clinical trials. Novartis AG, for instance, has been investing heavily in gene therapy research, leveraging its expertise in ophthalmology to develop novel treatments for retinal diseases, including Choroideremia.

In addition to corporate investments, academic and research institutions play a pivotal role in advancing the understanding of Choroideremia and developing new treatments. Collaborations between pharmaceutical companies and academic researchers are common, facilitating the translation of basic research findings into clinical applications. For example, ongoing clinical trials are often conducted in partnership with leading medical institutions, ensuring rigorous evaluation of new therapies.

The regulatory landscape for Choroideremia treatments is another critical factor shaping the market. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have established frameworks for the approval of gene therapies, which are categorized as advanced therapy medicinal products (ATMPs). These frameworks ensure that new treatments meet stringent safety and efficacy standards before they can be marketed. The approval of Luxturna (voretigene neparvovec-rzyl), a gene therapy for another inherited retinal disease, serves as a precedent and has paved the way for similar therapies targeting Choroideremia.

Patient advocacy groups also significantly impact the market by raising awareness about Choroideremia, funding research, and advocating for better access to treatments. Organizations such as the Choroideremia Research Foundation (CRF) and Fight for Sight provide essential support for research initiatives and clinical trials. Their efforts help bridge the gap between researchers, clinicians, and patients, fostering a collaborative environment that accelerates the development of effective therapies.

Segment Insights

By Distribution Channel, Hospital Pharmacies segment contributes the maximum revenue with a share of approximately 41.3% in 2023.

Gene therapy, a burgeoning area in the treatment of Choroideremia, involves the introduction of a functional copy of the CHM gene into retinal cells to compensate for the defective gene causing the disease. Hospital pharmacies play a pivotal role in this context by managing the logistics of gene therapy products, which often require stringent storage and handling conditions to maintain their efficacy. For instance, therapies like BIIB111 (developed by Biogen) and 4D-110 (developed by 4D Molecular Therapeutics) are advanced treatments that necessitate the sophisticated capabilities of hospital pharmacies for proper administration.

Geographical Insights

Americas represents the largest market in value terms, by region with a market share of 36.3% in the Global Choroideremia Treatment Market in 2023.

The Choroideremia treatment market in the Americas is characterized by significant advancements in medical research, robust healthcare infrastructure, and substantial investments in developing innovative therapies. Choroideremia, a rare inherited retinal disorder primarily affecting males, leads to progressive vision loss and eventual blindness due to the degeneration of the choroid, retinal pigment epithelium (RPE), and photoreceptors. This market's growth is driven by the increasing prevalence of the disease, the advancement of gene therapies, and supportive regulatory frameworks that facilitate the development and approval of new treatments.

In North America, the United States stands at the forefront of the Choroideremia treatment market. The country's leading position is attributed to its advanced healthcare system, high healthcare expenditure, and the presence of numerous pharmaceutical and biotechnology companies actively involved in research and development. Companies like Biogen, 4D Molecular Therapeutics, and Spark Therapeutics have been pivotal in developing gene therapies aimed at treating Choroideremia. Biogen's gene therapy candidate BIIB111 (formerly known as NSR-REP1) has shown promising results in clinical trials, demonstrating its potential to stabilize or improve visual function in patients with Choroideremia. Similarly, 4D Molecular Therapeutics is developing 4D-110, a gene therapy that uses a novel adeno-associated virus (AAV) vector to deliver the CHM gene to retinal cells, which has also shown encouraging early results.

Market Segmentation

By Treatment Type:

  • Gene Therapy
  • Topical Carbonic Inhibitor
  • Dorzolamide
  • Lutein
  • Luxturna

By Distribution Channel:

  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drugstores

By Route of Administration:

  • Oral & Intravenous
  • Ophthalmic

By Geography:

  • Americas (The United States, Canada, Brazil, Mexico, Rest of Americas)
  • Europe (United Kingdom, Germany, France, Italy, Spain, Turkey, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, South Korea, India, Singapore, Indonesia, Rest of Asia Pacific)
  • Middle East and Africa (GCC, Israel, South Africa, Rest of Middle East and Africa)

Key Companies

The report assesses the competitive developments, strategies, mergers and acquisitions and new product development and market share portfolio of top 15 companies. Key companies in the Global Choroideremia Treatment Market include:
  • F. Hoffmann-La Roche Ltd
  • Retina Implant AG
  • 4D Molecular Therapeutics
  • Biogen
  • Spark Therapeutics, Inc.
  • Copernicus Therapeutics, Inc.
  • Novartis AG
  • bluebird bio, Inc.
  • Wize Pharma Inc.
  • Pixium Vision
  • Other Leading Companies

Reasons to buy this report:

  • In-Depth Comparative Assessment of Top 20 Markets in the Choroideremia Treatment Industry: Comparative assessment of 20 leading countries highlighting the total addressable market, opportunities, lucrative segments and competitive positioning of leading companies.
  • Comprehensive Historical, Present, and Future Analytics of the Choroideremia Treatment Market: A deep dive in the historical (2020-2023), current (2024) and forecast (2025-2030) market analytics of Choroideremia Treatment Market.
  • Detailed Analysis of Choroideremia Treatment Market By Treatment Type, Distribution Channel, and Route of Administration Across 20 Countries
  • Beyond the Purchase: 90 Days of Support
  • Direct Access to Analysts: Have questions after reading the report? Our expert analysts are just a call or email away.
  • Customized Assistance: Whether you're integrating insights into your strategy or have questions about market dynamics, our team provides tailored support to meet your specific business needs.
  • Data Customization Requests: During the support period, you have the flexibility to request additional data cuts or deeper dives into specific areas of interest.
  • Gain insights specific to new entrants or new market areas to tap: The study provides detailed market entry strategies, including analysis of barriers to entry, pricing strategies, opportunities, trends, drivers, and challenges and product positioning using the Opportunity Portfolio Matrix (OPM)
  • Strategic Industry Movements: Tracking Competitive Developments and Key Players in the Market: The report covers competitive strategies, mergers & acquisitions, new developments, future plans and market share analysis of ~15 top companies


This product will be delivered within 2 business days.

Table of Contents

1. Market Background
1.1 Scope and Service Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Analyst Recommendations
3. Global Choroideremia Treatment Market: Historic and Forecast
3.1 Impact Analysis of Macro Economic Factors on Global Choroideremia Treatment Market
3.2 Choroideremia Treatment Drugs Clinical Trials
3.3 Choroideremia Treatment Drugs Pipeline
3.4 Global Choroideremia Treatment Market: Dashboard
3.5 Global Choroideremia Treatment Market: Market Size and CAGR, By Value, 2020-2030 (USD Billion & CAGR)
3.6 Global Choroideremia Treatment Market: Epidemiology Analysis
3.7 Global Choroideremia Treatment Market: Market Value Assessment
3.8 Assessment of Degree Impact of COVID-19 on Global Choroideremia Treatment Market
3.9 Global Choroideremia Treatment Market Segmentation : By Treatment Type
3.9.1 Global Choroideremia Treatment Market, By Treatment Type Overview
3.9.2 Global Choroideremia Treatment Market Attractiveness Index, By Treatment Type (2025-2030)
3.9.3 Global Choroideremia Treatment Market Size, By Gene Therapy, By Value, 2020H-2030F (USD Billion & CAGR)
3.9.4 Global Choroideremia Treatment Market Size, By Topical Carbonic Inhibitor, By Value, 2020H-2030F (USD Billion & CAGR)
3.9.5 Global Choroideremia Treatment Market Size, By Dorzolamide, By Value, 2020H-2030F (USD Billion & CAGR)
3.9.6 Global Choroideremia Treatment Market Size, By Lutein , By Value, 2020H-2030F (USD Billion & CAGR)
3.9.7 Global Choroideremia Treatment Market Size, By Luxturna, By Value, 2020H-2030F (USD Billion & CAGR)
3.10 Global Choroideremia Treatment Market Segmentation : By Distribution Channel
3.10.1 Global Choroideremia Treatment Market, By Distribution Channel Overview
3.10.2 Global Choroideremia Treatment Market Attractiveness Index, By Distribution Channel (2025-2030)
3.10.3 Global Choroideremia Treatment Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
3.10.4 Global Choroideremia Treatment Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
3.10.5 Global Choroideremia Treatment Market Size, By Retail Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
3.10.6 Global Choroideremia Treatment Market Size, By Drugstores, By Value, 2020H-2030F (USD Billion & CAGR)
3.11 Global Choroideremia Treatment Market Segmentation : By Route of Administration
3.11.1 Global Choroideremia Treatment Market, By Route of Administration Overview
3.11.2 Global Choroideremia Treatment Market Attractiveness Index, By Route of Administration (2025-2030)
3.11.3 Global Choroideremia Treatment Market Size, By Oral & Intravenous, By Value, 2020H-2030F (USD Billion & CAGR)
3.11.4 Global Choroideremia Treatment Market Size, By Ophthalmic, By Value, 2020H-2030F (USD Billion & CAGR)
4. Choroideremia Treatment Market, Region Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
5. Americas Choroideremia Treatment Market: Historic and Forecast
5.1 Americas Choroideremia Treatment Market: Snapshot
5.2 Americas Choroideremia Treatment Market: Market Size and CAGR, By Value, 2020-2030 (USD Billion & CAGR)
5.3 Americas Choroideremia Treatment Market: Epidemiology Analysis
5.4 Americas Choroideremia Treatment Market: Key Factors
5.5 Americas Choroideremia Treatment Market: Segment Analysis
5.6 Americas Choroideremia Treatment Market Segmentation : By Treatment Type
5.6.1 Americas Choroideremia Treatment Market, By Treatment Type Overview
5.6.2 Americas Choroideremia Treatment Market Size, By Gene Therapy, By Value, 2020H-2030F (USD Billion & CAGR)
5.6.3 Americas Choroideremia Treatment Market Size, By Topical Carbonic Inhibitor, By Value, 2020H-2030F (USD Billion & CAGR)
5.6.4 Americas Choroideremia Treatment Market Size, By Dorzolamide, By Value, 2020H-2030F (USD Billion & CAGR)
5.6.5 Americas Choroideremia Treatment Market Size, By Lutein , By Value, 2020H-2030F (USD Billion & CAGR)
5.6.6 Americas Choroideremia Treatment Market Size, By Luxturna, By Value, 2020H-2030F (USD Billion & CAGR)
5.7 Americas Choroideremia Treatment Market Segmentation : By Distribution Channel
5.7.1 Americas Choroideremia Treatment Market, By Distribution Channel Overview
5.7.2 Americas Choroideremia Treatment Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
5.7.3 Americas Choroideremia Treatment Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
5.7.4 Americas Choroideremia Treatment Market Size, By Retail Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
5.7.5 Americas Choroideremia Treatment Market Size, By Drugstores, By Value, 2020H-2030F (USD Billion & CAGR)
5.8 Americas Choroideremia Treatment Market Segmentation : By Route of Administration
5.8.1 Americas Choroideremia Treatment Market, By Route of Administration Overview
5.8.2 Americas Choroideremia Treatment Market Size, By Oral & Intravenous, By Value, 2020H-2030F (USD Billion & CAGR)
5.8.3 Americas Choroideremia Treatment Market Size, By Ophthalmic, By Value, 2020H-2030F (USD Billion & CAGR)
5.9 Americas Choroideremia Treatment Market Segmentation : By Country
5.9.1 Americas Choroideremia Treatment Market, by Country Overview
5.9.2 United States Choroideremia Treatment Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.9.2.1 United States Choroideremia Treatment Market, By Treatment Type
5.9.2.2 United States Choroideremia Treatment Market, By Distribution Channel
5.9.2.3 United States Choroideremia Treatment Market, By Route of Administration
5.9.3 Canada Choroideremia Treatment Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.9.3.1 Canada Choroideremia Treatment Market, By Treatment Type
5.9.3.2 Canada Choroideremia Treatment Market, By Distribution Channel
5.9.3.3 Canada Choroideremia Treatment Market, By Route of Administration
5.9.4 Brazil Choroideremia Treatment Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.9.4.1 Brazil Choroideremia Treatment Market, By Treatment Type
5.9.4.2 Brazil Choroideremia Treatment Market, By Distribution Channel
5.9.4.3 Brazil Choroideremia Treatment Market, By Route of Administration
5.9.5 Mexico Choroideremia Treatment Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.9.5.1 Mexico Choroideremia Treatment Market, By Treatment Type
5.9.5.2 Mexico Choroideremia Treatment Market, By Distribution Channel
5.9.5.3 Mexico Choroideremia Treatment Market, By Route of Administration
5.9.6 Rest of Americas Choroideremia Treatment Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.9.6.1 Rest of Americas Choroideremia Treatment Market, By Treatment Type
5.9.6.2 Rest of Americas Choroideremia Treatment Market, By Distribution Channel
5.9.6.3 Rest of Americas Choroideremia Treatment Market, By Route of Administration
6. Europe Choroideremia Treatment Market: Historic and Forecast
6.1 Europe Choroideremia Treatment Market: Snapshot
6.2 Europe Choroideremia Treatment Market: Market Size and CAGR, BY Value, 2020-2030 (USD Billion & CAGR)
6.3 Europe Choroideremia Treatment Market: Epidemiology Analysis
6.4 Europe Choroideremia Treatment Market: Key Factors
6.5 Europe Choroideremia Treatment Market: Segment Analysis
6.6 Europe Choroideremia Treatment Market Segmentation : By Treatment Type
6.6.1 Europe Choroideremia Treatment Market, By Treatment Type Overview
6.6.2 Europe Choroideremia Treatment Market Size, By Gene Therapy, By Value, 2020H-2030F (USD Billion & CAGR)
6.6.3 Europe Choroideremia Treatment Market Size, By Topical Carbonic Inhibitor, By Value, 2020H-2030F (USD Billion & CAGR)
6.6.4 Europe Choroideremia Treatment Market Size, By Dorzolamide, By Value, 2020H-2030F (USD Billion & CAGR)
6.6.5 Europe Choroideremia Treatment Market Size, By Lutein , By Value, 2020H-2030F (USD Billion & CAGR)
6.6.6 Europe Choroideremia Treatment Market Size, By Luxturna, By Value, 2020H-2030F (USD Billion & CAGR)
6.7 Europe Choroideremia Treatment Market Segmentation : By Distribution Channel
6.7.1 Europe Choroideremia Treatment Market, By Distribution Channel Overview
6.7.2 Europe Choroideremia Treatment Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
6.7.3 Europe Choroideremia Treatment Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
6.7.4 Europe Choroideremia Treatment Market Size, By Retail Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
6.7.5 Europe Choroideremia Treatment Market Size, By Drugstores, By Value, 2020H-2030F (USD Billion & CAGR)
6.8 Europe Choroideremia Treatment Market Segmentation : By Route of Administration
6.8.1 Europe Choroideremia Treatment Market, By Route of Administration Overview
6.8.2 Europe Choroideremia Treatment Market Size, By Oral & Intravenous, By Value, 2020H-2030F (USD Billion & CAGR)
6.8.3 Europe Choroideremia Treatment Market Size, By Ophthalmic, By Value, 2020H-2030F (USD Billion & CAGR)
6.9 Europe Choroideremia Treatment Market Segmentation : By Country
6.9.1 Europe Choroideremia Treatment Market, by Country Overview
6.9.2 Russia Choroideremia Treatment Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.9.2.1 Russia Choroideremia Treatment Market, By Treatment Type
6.9.2.2 Russia Choroideremia Treatment Market, By Distribution Channel
6.9.2.3 Russia Choroideremia Treatment Market, By Route of Administration
6.9.3 France Choroideremia Treatment Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.9.3.1 France Choroideremia Treatment Market, By Treatment Type
6.9.3.2 France Choroideremia Treatment Market, By Distribution Channel
6.9.3.3 France Choroideremia Treatment Market, By Route of Administration
6.9.4 United Kingdom Choroideremia Treatment Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.9.4.1 United Kingdom Choroideremia Treatment Market, By Treatment Type
6.9.4.2 United Kingdom Choroideremia Treatment Market, By Distribution Channel
6.9.4.3 United Kingdom Choroideremia Treatment Market, By Route of Administration
6.9.5 Germany Choroideremia Treatment Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.9.5.1 Germany Choroideremia Treatment Market, By Treatment Type
6.9.5.2 Germany Choroideremia Treatment Market, By Distribution Channel
6.9.5.3 Germany Choroideremia Treatment Market, By Route of Administration
6.9.6 Italy Choroideremia Treatment Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.9.6.1 Italy Choroideremia Treatment Market, By Treatment Type
6.9.6.2 Italy Choroideremia Treatment Market, By Distribution Channel
6.9.6.3 Italy Choroideremia Treatment Market, By Route of Administration
6.9.7 Spain Choroideremia Treatment Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.9.7.1 Spain Choroideremia Treatment Market, By Treatment Type
6.9.7.2 Spain Choroideremia Treatment Market, By Distribution Channel
6.9.7.3 Spain Choroideremia Treatment Market, By Route of Administration
6.9.8 Turkey Choroideremia Treatment Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.9.8.1 Turkey Choroideremia Treatment Market, By Treatment Type
6.9.8.2 Turkey Choroideremia Treatment Market, By Distribution Channel
6.9.8.3 Turkey Choroideremia Treatment Market, By Route of Administration
6.9.9 Rest of Europe Choroideremia Treatment Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.9.9.1 Rest of Europe Choroideremia Treatment Market, By Treatment Type
6.9.9.2 Rest of Europe Choroideremia Treatment Market, By Distribution Channel
6.9.9.3 Rest of Europe Choroideremia Treatment Market, By Route of Administration
7. Asia Pacific Choroideremia Treatment Market: Historic and Forecast
7.1 Asia Pacific Choroideremia Treatment Market: Snapshot
7.2 Asia Pacific Choroideremia Treatment Market: Market Size and CAGR, By Value, 2020-2030 (USD Billion & CAGR)
7.3 Asia Pacific Choroideremia Treatment Market: Epidemiology Analysis
7.4 Asia Pacific Choroideremia Treatment Market: Key Factors
7.5 Asia Pacific Choroideremia Treatment Market: Segment Analysis
7.6 Asia Pacific Choroideremia Treatment Market Segmentation : By Treatment Type
7.6.1 Asia Pacific Choroideremia Treatment Market, By Treatment Type Overview
7.6.2 Asia Pacific Choroideremia Treatment Market Size, By Gene Therapy, By Value, 2020H-2030F (USD Billion & CAGR)
7.6.3 Asia Pacific Choroideremia Treatment Market Size, By Topical Carbonic Inhibitor, By Value, 2020H-2030F (USD Billion & CAGR)
7.6.4 Asia Pacific Choroideremia Treatment Market Size, By Dorzolamide, By Value, 2020H-2030F (USD Billion & CAGR)
7.6.5 Asia Pacific Choroideremia Treatment Market Size, By Lutein , By Value, 2020H-2030F (USD Billion & CAGR)
7.6.6 Asia Pacific Choroideremia Treatment Market Size, By Luxturna, By Value, 2020H-2030F (USD Billion & CAGR)
7.7 Asia Pacific Choroideremia Treatment Market Segmentation : By Distribution Channel
7.7.1 Asia Pacific Choroideremia Treatment Market, By Distribution Channel Overview
7.7.2 Asia Pacific Choroideremia Treatment Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
7.7.3 Asia Pacific Choroideremia Treatment Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
7.7.4 Asia Pacific Choroideremia Treatment Market Size, By Retail Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
7.7.5 Asia Pacific Choroideremia Treatment Market Size, By Drugstores, By Value, 2020H-2030F (USD Billion & CAGR)
7.8 Asia Pacific Choroideremia Treatment Market Segmentation : By Route of Administration
7.8.1 Asia Pacific Choroideremia Treatment Market, By Route of Administration Overview
7.8.2 Asia Pacific Choroideremia Treatment Market Size, By Oral & Intravenous, By Value, 2020H-2030F (USD Billion & CAGR)
7.8.3 Asia Pacific Choroideremia Treatment Market Size, By Ophthalmic, By Value, 2020H-2030F (USD Billion & CAGR)
7.9 Asia Pacific Choroideremia Treatment Market Segmentation : By Country
7.9.1 Asia Pacific Choroideremia Treatment Market, by Country Overview
7.9.2 China Choroideremia Treatment Market : Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.9.2.1 China Choroideremia Treatment Market, By Treatment Type
7.9.2.2 China Choroideremia Treatment Market, By Distribution Channel
7.9.2.3 China Choroideremia Treatment Market, By Route of Administration
7.9.3 India Choroideremia Treatment Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.9.3.1 India Choroideremia Treatment Market, By Treatment Type
7.9.3.2 India Choroideremia Treatment Market, By Distribution Channel
7.9.3.3 India Choroideremia Treatment Market, By Route of Administration
7.9.4 South Korea Choroideremia Treatment Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.9.4.1 South Korea Choroideremia Treatment Market, By Treatment Type
7.9.4.2 South Korea Choroideremia Treatment Market, By Distribution Channel
7.9.4.3 South Korea Choroideremia Treatment Market, By Route of Administration
7.9.5 Japan Korea Choroideremia Treatment Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.9.5.1 Japan Choroideremia Treatment Market, By Treatment Type
7.9.5.2 Japan Choroideremia Treatment Market, By Distribution Channel
7.9.5.3 Japan Choroideremia Treatment Market, By Route of Administration
7.9.6 Singapore Choroideremia Treatment Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.9.6.1 Singapore Choroideremia Treatment Market, By Treatment Type
7.9.6.2 Singapore Choroideremia Treatment Market, By Distribution Channel
7.9.6.3 Singapore Choroideremia Treatment Market, By Route of Administration
7.9.7 Indonesia Choroideremia Treatment Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.9.7.1 Indonesia Choroideremia Treatment Market, By Treatment Type
7.9.7.2 Indonesia Choroideremia Treatment Market, By Distribution Channel
7.9.7.3 Indonesia Choroideremia Treatment Market, By Route of Administration
7.9.8 Rest of Asia Pacific Choroideremia Treatment Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.9.8.1 Rest of Asia Pacific Choroideremia Treatment Market, By Treatment Type
7.9.8.2 Rest of Asia Pacific Choroideremia Treatment Market, By Distribution Channel
7.9.8.3 Rest of Asia Pacific Choroideremia Treatment Market, By Route of Administration
8. Middle East & Africa Choroideremia Treatment Market: Historic and Forecast
8.1 Middle East & Africa Choroideremia Treatment Market: Snapshot
8.2 Middle East & Africa Choroideremia Treatment Market: Market Size and CAGR, By Value, 2020-2030 (USD Billion & CAGR)
8.3 Middle East & Africa Choroideremia Treatment Market: Epidemiology Analysis
8.4 Middle East & Africa Choroideremia Treatment Market: Key Factors
8.5 Middle East and Africa Choroideremia Treatment Market: Segment Analysis
8.6 Middle East & Africa Choroideremia Treatment Market Segmentation : By Treatment Type
8.6.1 Middle East & Africa Choroideremia Treatment Market, By Treatment Type Overview
8.6.2 Middle East & Africa Choroideremia Treatment Market Size, By Gene Therapy, By Value, 2020H-2030F (USD Billion & CAGR)
8.6.3 Middle East & Africa Choroideremia Treatment Market Size, By Topical Carbonic Inhibitor, By Value, 2020H-2030F (USD Billion & CAGR)
8.6.4 Middle East & Africa Choroideremia Treatment Market Size, By Dorzolamide, By Value, 2020H-2030F (USD Billion & CAGR)
8.6.5 Middle East & Africa Choroideremia Treatment Market Size, By Lutein , By Value, 2020H-2030F (USD Billion & CAGR)
8.6.6 Middle East & Africa Choroideremia Treatment Market Size, By Luxturna, By Value, 2020H-2030F (USD Billion & CAGR)
8.7 Middle East & Africa Choroideremia Treatment Market Segmentation : By Distribution Channel
8.7.1 Middle East & Africa Choroideremia Treatment Market, By Distribution Channel Overview
8.7.2 Middle East & Africa Choroideremia Treatment Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
8.7.3 Middle East & Africa Choroideremia Treatment Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
8.7.4 Middle East & Africa Choroideremia Treatment Market Size, By Retail Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
8.7.5 Middle East & Africa Choroideremia Treatment Market Size, By Drugstores, By Value, 2020H-2030F (USD Billion & CAGR)
8.8 Middle East & Africa Choroideremia Treatment Market Segmentation : By Route of Administration
8.8.1 Middle East & Africa Choroideremia Treatment Market, By Route of Administration Overview
8.8.2 Middle East & Africa Choroideremia Treatment Market Size, By Oral & Intravenous, By Value, 2020H-2030F (USD Billion & CAGR)
8.8.3 Middle East & Africa Choroideremia Treatment Market Size, By Ophthalmic, By Value, 2020H-2030F (USD Billion & CAGR)
8.8.4 Middle East & Africa Choroideremia Treatment Market, by Country Overview
8.8.5 GCC Choroideremia Treatment Market : Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
8.8.5.1 GCC Choroideremia Treatment Market, By Treatment Type
8.8.5.2 GCC Choroideremia Treatment Market, By Distribution Channel
8.8.5.3 GCC Choroideremia Treatment Market, By Route of Administration
8.8.6 Israel Choroideremia Treatment Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
8.8.6.1 Israel Choroideremia Treatment Market, By Treatment Type
8.8.6.2 Israel Choroideremia Treatment Market, By Distribution Channel
8.8.6.3 Israel Choroideremia Treatment Market, By Route of Administration
8.8.7 South Africa Choroideremia Treatment Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
8.8.7.1 South Africa Choroideremia Treatment Market, By Treatment Type
8.8.7.2 South Africa Choroideremia Treatment Market, By Distribution Channel
8.8.7.3 South Africa Choroideremia Treatment Market, By Route of Administration
8.8.8 Rest of Middle East and Africa Choroideremia Treatment Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
8.8.8.1 Rest of Middle East and Africa Choroideremia Treatment Market, By Treatment Type
8.8.8.2 Rest of Middle East and Africa Choroideremia Treatment Market, By Distribution Channel
8.8.8.3 Rest of Middle East and Africa Choroideremia Treatment Market, By Route of Administration
9. Market Dynamics
9.1 Impact assessment of Market Dynamics on Choroideremia Treatment Market
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Industry Ecosystem Analysis
10.1 Porter Analysis
11. Competitive Positioning
11.1 Companies’ Service Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Choroideremia Treatment Market
11.4 Company Profiles
11.4.1. F. Hoffmann-La Roche Ltd
11.4.2. Retina Implant AG
11.4.3. 4D Molecular Therapeutics
11.4.4. Biogen
11.4.5. Spark Therapeutics, Inc.
11.4.6. Copernicus Therapeutics, Inc.
11.4.7. Novartis AG
11.4.8. bluebird bio, Inc.
11.4.9. Wize Pharma Inc.
11.4.10. Pixium Vision
11.4.11. Other Leading Companies
12. About the Publisher & Disclaimer
List of Figures
Figure 1: Prevalence of Choroideremia Treatment (% of Ophthalmic Diseases), 2023 (%)
Figure 2: Prevalence of Choroideremia Treatment (% of Ophthalmic Diseases), 2030 (%)
Figure 3: Choroideremia Treatment Drugs Pipeline
Figure 4: Choroideremia Number of Trials
Figure 5: Global Choroideremia Treatment Market Size, By Value, 2020-2023 (USD Billion)
Figure 6: Global Choroideremia Treatment Market Size, By Value, 2024-2030 (USD Billion)
Figure 7: Global Choroideremia Treatment Market Share, By Distribution Channel, 2023 (%)
Figure 8: Global Choroideremia Treatment Market Size, Number of drugs, 2020-2023 (in Number)
Figure 9: Global Choroideremia Treatment Market Size, By Number of drugs, 2024-2030 (in Number)
Figure 10: Global Choroideremia Treatment Market CAGR (%), By Volume, 2020-2023, 2025-2030
Figure 11: Market Attractiveness Analysis of Global Choroideremia Treatment Market, By Treatment Type (2025-2030)
Figure 12: Global Choroideremia Treatment Market Size, By Gene Therapy, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 13: Global Choroideremia Treatment Market Absolute Opportunity, By Gene Therapy, 2020-2030 (USD Billion)
Figure 14: Global Choroideremia Treatment Market Size, By Topical Carbonic Inhibitor, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 15: Global Choroideremia Treatment Market Absolute Opportunity, By Topical Carbonic Inhibitor, 2020-2030 (USD Billion)
Figure 16: Global Choroideremia Treatment Market Size, By Dorzolamide, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 17: Global Choroideremia Treatment Market Absolute Opportunity, By Dorzolamide, 2020-2030 (USD Billion)
Figure 18: Global Choroideremia Treatment Market Size, By Lutein , By Value, 2020H-2030F (USD Billion & CAGR)
Figure 19: Global Choroideremia Treatment Market Absolute Opportunity, By Lutein , 2020-2030 (USD Billion)
Figure 20: Global Choroideremia Treatment Market Size, By Luxturna, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 21: Global Choroideremia Treatment Market Absolute Opportunity, By Luxturna, 2020-2030 (USD Billion)
Figure 22: Market Attractiveness Analysis of Global Choroideremia Treatment Market, By Distribution Channel (2025-2030)
Figure 23: Global Choroideremia Treatment Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 24: Global Choroideremia Treatment Market Absolute Opportunity, By Online Pharmacies, 2020-2030 (USD Billion)
Figure 25: Global Choroideremia Treatment Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 26: Global Choroideremia Treatment Market Absolute Opportunity, By Hospital Pharmacies, 2020-2030 (USD Billion)
Figure 27: Global Choroideremia Treatment Market Size, By Retail Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 28: Global Choroideremia Treatment Market Absolute Opportunity, By Retail Pharmacies, 2020-2030 (USD Billion)
Figure 29: Global Choroideremia Treatment Market Size, By Drugstores, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 30: Global Choroideremia Treatment Market Absolute Opportunity, By Drugstores, 2020-2030 (USD Billion)
Figure 31: Market Attractiveness Analysis of Global Choroideremia Treatment Market, By Route of Administration (2025-2030)
Figure 32: Global Choroideremia Treatment Market Size, By Oral & Intravenous, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 33: Global Choroideremia Treatment Market Absolute Opportunity, By Oral & Intravenous, 2020-2030 (USD Billion)
Figure 34: Global Choroideremia Treatment Market Size, By Ophthalmic, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 35: Global Choroideremia Treatment Market Absolute Opportunity, By Ophthalmic, 2020-2030 (USD Billion)
Figure 36: Americas Choroideremia Treatment Market Size, By Value, 2020H-2030F (USD Billion)
Figure 37: Americas Choroideremia Treatment Market Share, By Distribution Channel, 2023 (%)
Figure 38: Americas Choroideremia Treatment Market Size, By Volume, 2020-2023 (in Number of Drugs)
Figure 39: Americas Choroideremia Treatment Market Size, By Volume, 2024-2030 (in Number of Drugs)
Figure 40: Americas Choroideremia Treatment Market CAGR (%), By Volume, 2020-2023, 2025-2030
Figure 41: Americas Choroideremia Treatment Market, By Gene Therapy, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 42: Americas Choroideremia Treatment Market, By Topical Carbonic Inhibitor, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 43: Americas Choroideremia Treatment Market, By Dorzolamide, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 44: Americas Choroideremia Treatment Market, By Lutein , By Value, 2020H-2030F (USD Billions & CAGR)
Figure 45: Americas Choroideremia Treatment Market, By Luxturna, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 46: Americas Choroideremia Treatment Market, By Online Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 47: Americas Choroideremia Treatment Market, By Hospital Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 48: Americas Choroideremia Treatment Market, By Retail Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 49: Americas Choroideremia Treatment Market, By Drugstores, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 50: Americas Choroideremia Treatment Market, By Oral & Intravenous, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 51: Americas Choroideremia Treatment Market, By Ophthalmic, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 52: United States Choroideremia Treatment Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 53: United States Choroideremia Treatment Market Value, By Route of Administration, 2023 (USD Billion)
Figure 54: United States Choroideremia Treatment Market Share, By Treatment Type, By Value, 2023 (%)
Figure 55: United States Choroideremia Treatment Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 56: United States Choroideremia Treatment Market Share, By Route of Administration, By Value, 2023 (%)
Figure 57: Canada Choroideremia Treatment Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 58: Canada Choroideremia Treatment Market Value, By Route of Administration, 2023 (USD Billion)
Figure 59: Canada Choroideremia Treatment Market Share, By Treatment Type, By Value, 2023 (%)
Figure 60: Canada Choroideremia Treatment Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 61: Canada Choroideremia Treatment Market Share, By Route of Administration, By Value, 2023 (%)
Figure 62: Brazil Choroideremia Treatment Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 63: Brazil Choroideremia Treatment Market Value, By Route of Administration, 2023 (USD Billion)
Figure 64: Brazil Choroideremia Treatment Market Share, By Treatment Type, By Value, 2023 (%)
Figure 65: Brazil Choroideremia Treatment Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 66: Brazil Choroideremia Treatment Market Share, By Route of Administration, By Value, 2023 (%)
Figure 67: Mexico Choroideremia Treatment Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 68: Mexico Choroideremia Treatment Market Value, By Route of Administration, 2023 (USD Billion)
Figure 69: Mexico Choroideremia Treatment Market Share, By Treatment Type, By Value, 2023 (%)
Figure 70: Mexico Choroideremia Treatment Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 71: Mexico Choroideremia Treatment Market Share, By Route of Administration, By Value, 2023 (%)
Figure 72: Rest of Americas Choroideremia Treatment Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 73: Rest of Americas Choroideremia Treatment Market Value, By Route of Administration, 2023 (USD Billion)
Figure 74: Rest of Americas Choroideremia Treatment Market Share, By Treatment Type, By Value, 2023 (%)
Figure 75: Rest of Americas Choroideremia Treatment Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 76: Rest of Americas Choroideremia Treatment Market Share, By Route of Administration, By Value, 2023 (%)
Figure 77: Europe Choroideremia Treatment Market Size, By Value, 2020H-2030F (USD Billion)
Figure 78: Europe Choroideremia Treatment Market Share, By Distribution Channel, 2023 (%)
Figure 79: Europe Choroideremia Treatment Market Size, By Volume, 2020-2023 (in Number of Drugs)
Figure 80: Europe Choroideremia Treatment Market Size, By Volume, 2024-2030 (in Number of Drugs)
Figure 81: Europe Choroideremia Treatment Market CAGR (%), By Volume, 2020-2023, 2025-2030
Figure 82: Europe Choroideremia Treatment Market, By Gene Therapy, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 83: Europe Choroideremia Treatment Market, By Topical Carbonic Inhibitor, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 84: Europe Choroideremia Treatment Market, By Dorzolamide, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 85: Europe Choroideremia Treatment Market, By Lutein , By Value, 2020H-2030F (USD Billions & CAGR)
Figure 86: Europe Choroideremia Treatment Market, By Luxturna, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 87: Europe Choroideremia Treatment Market, By Online Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 88: Europe Choroideremia Treatment Market, By Hospital Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 89: Europe Choroideremia Treatment Market, By Retail Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 90: Europe Choroideremia Treatment Market, By Drugstores, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 91: Europe Choroideremia Treatment Market, By Oral & Intravenous, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 92: Europe Choroideremia Treatment Market, By Ophthalmic, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 93: Russia Choroideremia Treatment Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 94: Russia Choroideremia Treatment Market Value, By Route of Administration, 2023 (USD Billion)
Figure 95: Russia Choroideremia Treatment Market Share, By Treatment Type, By Value, 2023 (%)
Figure 96: Russia Choroideremia Treatment Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 97: Russia Choroideremia Treatment Market Share, By Route of Administration, By Value, 2023 (%)
Figure 98: France Choroideremia Treatment Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 99: France Choroideremia Treatment Market Value, By Route of Administration, 2023 (USD Billion)
Figure 100: France Choroideremia Treatment Market Share, By Treatment Type, By Value, 2023 (%)
Figure 101: France Choroideremia Treatment Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 102: France Choroideremia Treatment Market Share, By Route of Administration, By Value, 2023 (%)
Figure 103: United Kingdom Choroideremia Treatment Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 104: United Kingdom Choroideremia Treatment Market Value, By Route of Administration, 2023 (USD Billion)
Figure 105: United Kingdom Choroideremia Treatment Market Share, By Treatment Type, By Value, 2023 (%)
Figure 106: United Kingdom Choroideremia Treatment Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 107: United Kingdom Choroideremia Treatment Market Share, By Route of Administration, By Value, 2023 (%)
Figure 108: Germany Choroideremia Treatment Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 109: Germany Choroideremia Treatment Market Value, By Route of Administration, 2023 (USD Billion)
Figure 110: Germany Choroideremia Treatment Market Share, By Treatment Type, By Value, 2023 (%)
Figure 111: Germany Choroideremia Treatment Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 112: Germany Choroideremia Treatment Market Share, By Route of Administration, By Value, 2023 (%)
Figure 113: Italy Choroideremia Treatment Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 114: Italy Choroideremia Treatment Market Value, By Route of Administration, 2023 (USD Billion)
Figure 115: Italy Choroideremia Treatment Market Share, By Treatment Type, By Value, 2023 (%)
Figure 116: Italy Choroideremia Treatment Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 117: Italy Choroideremia Treatment Market Share, By Route of Administration, By Value, 2023 (%)
Figure 118: Spain Choroideremia Treatment Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 119: Spain Choroideremia Treatment Market Value, By Route of Administration, 2023 (USD Billion)
Figure 120: Spain Choroideremia Treatment Market Share, By Treatment Type, By Value, 2023 (%)
Figure 121: Spain Choroideremia Treatment Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 122: Spain Choroideremia Treatment Market Share, By Route of Administration, By Value, 2023 (%)
Figure 123: Turkey Choroideremia Treatment Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 124: Turkey Choroideremia Treatment Market Value, By Route of Administration, 2023 (USD Billion)
Figure 125: Turkey Choroideremia Treatment Market Share, By Treatment Type, By Value, 2023 (%)
Figure 126: Turkey Choroideremia Treatment Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 127: Turkey Choroideremia Treatment Market Share, By Route of Administration, By Value, 2023 (%)
Figure 128: Rest of Europe Choroideremia Treatment Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 129: Rest of Europe Choroideremia Treatment Market Value, By Route of Administration, 2023 (USD Billion)
Figure 130: Rest of Europe Choroideremia Treatment Market Share, By Treatment Type, By Value, 2023 (%)
Figure 131: Rest of Europe Choroideremia Treatment Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 132: Rest of Europe Choroideremia Treatment Market Share, By Route of Administration, By Value, 2023 (%)
Figure 133: Asia Pacific Choroideremia Treatment Market Size, By Value, 2020H-2030F (USD Billion)
Figure 134: Asia Pacific Choroideremia Treatment Market Share, By Distribution Channel, 2023 (%)
Figure 135: Asia Pacific Choroideremia Treatment Market Size, By Volume, 2020-2023 (in Number of Drugs)
Figure 136: Asia Pacific Choroideremia Treatment Market Size, By Volume, 2024-2030 (in Number of Drugs)
Figure 137: Asia Pacific Choroideremia Treatment Market CAGR (%), By Volume, 2020-2023, 2025-2030
Figure 138: Asia Pacific Choroideremia Treatment Market, By Gene Therapy, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 139: Asia Pacific Choroideremia Treatment Market, By Topical Carbonic Inhibitor, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 140: Asia Pacific Choroideremia Treatment Market, By Dorzolamide, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 141: Asia Pacific Choroideremia Treatment Market, By Lutein , By Value, 2020H-2030F (USD Billions & CAGR)
Figure 142: Asia Pacific Choroideremia Treatment Market, By Luxturna, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 143: Asia Pacific Choroideremia Treatment Market, By Online Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 144: Asia Pacific Choroideremia Treatment Market, By Hospital Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 145: Asia Pacific Choroideremia Treatment Market, By Retail Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 146: Asia Pacific Choroideremia Treatment Market, By Drugstores, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 147: Asia Pacific Choroideremia Treatment Market, By Oral & Intravenous, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 148: Asia Pacific Choroideremia Treatment Market, By Ophthalmic, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 149: China Choroideremia Treatment Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 150: China Choroideremia Treatment Market Value, By Route of Administration, 2023 (USD Billion)
Figure 151: China Choroideremia Treatment Market Share, By Treatment Type, By Value, 2023 (%)
Figure 152: China Choroideremia Treatment Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 153: China Choroideremia Treatment Market Share, By Route of Administration, By Value, 2023 (%)
Figure 154: India Choroideremia Treatment Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 155: India Choroideremia Treatment Market Value, By Route of Administration, 2023 (USD Billion)
Figure 156: India Choroideremia Treatment Market Share, By Treatment Type, By Value, 2023 (%)
Figure 157: India Choroideremia Treatment Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 158: India Choroideremia Treatment Market Share, By Route of Administration, By Value, 2023 (%)
Figure 159: South Korea Choroideremia Treatment Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 160: South Korea Choroideremia Treatment Market Value, By Route of Administration, 2023 (USD Billion)
Figure 161: South Korea Choroideremia Treatment Market Share, By Treatment Type, By Value, 2023 (%)
Figure 162: South Korea Choroideremia Treatment Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 163: South Korea Choroideremia Treatment Market Share, By Route of Administration, By Value, 2023 (%)
Figure 164: Japan Choroideremia Treatment Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 165: Japan Choroideremia Treatment Market Value, By Route of Administration, 2023 (USD Billion)
Figure 166: Japan Choroideremia Treatment Market Share, By Treatment Type, By Value, 2023 (%)
Figure 167: Japan Choroideremia Treatment Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 168: Japan Choroideremia Treatment Market Share, By Route of Administration, By Value, 2023 (%)
Figure 169: Singapore Choroideremia Treatment Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 170: Singapore Choroideremia Treatment Market Value, By Route of Administration, 2023 (USD Billion)
Figure 171: Singapore Choroideremia Treatment Market Share, By Treatment Type, By Value, 2023 (%)
Figure 172: Singapore Choroideremia Treatment Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 173: Singapore Choroideremia Treatment Market Share, By Route of Administration, By Value, 2023 (%)
Figure 174: Indonesia Choroideremia Treatment Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 175: Indonesia Choroideremia Treatment Market Value, By Route of Administration, 2023 (USD Billion)
Figure 176: Indonesia Choroideremia Treatment Market Share, By Treatment Type, By Value, 2023 (%)
Figure 177: Indonesia Choroideremia Treatment Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 178: Indonesia Choroideremia Treatment Market Share, By Route of Administration, By Value, 2023 (%)
Figure 179: Rest of Asia Pacific Choroideremia Treatment Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 180: Rest of Asia Pacific Choroideremia Treatment Market Value, By Route of Administration, 2023 (USD Billion)
Figure 181: Rest of Asia Pacific Choroideremia Treatment Market Share, By Treatment Type, By Value, 2023 (%)
Figure 182: Rest of Asia Pacific Choroideremia Treatment Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 183: Rest of Asia Pacific Choroideremia Treatment Market Share, By Route of Administration, By Value, 2023 (%)
Figure 184: Middle East and Africa Choroideremia Treatment Market Size, By Value, 2020H-2030F (USD Billion)
Figure 185: Middle East and Africa Choroideremia Treatment Market Share, By Distribution Channel, 2023 (%)
Figure 186: Middle East and Africa Choroideremia Treatment Market Size, By Volume, 2020-2023 (in Number of Drugs)
Figure 187: Middle East and Africa Choroideremia Treatment Market Size, By Volume, 2024-2030 (in Number of Drugs)
Figure 188: Middle East and Africa Choroideremia Treatment Market CAGR (%), By Volume, 2020-2023, 2025-2030
Figure 189: Middle East and Africa Choroideremia Treatment Market, By Gene Therapy, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 190: Middle East and Africa Choroideremia Treatment Market, By Topical Carbonic Inhibitor, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 191: Middle East and Africa Choroideremia Treatment Market, By Dorzolamide, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 192: Middle East and Africa Choroideremia Treatment Market, By Lutein , By Value, 2020H-2030F (USD Billions & CAGR)
Figure 193: Middle East and Africa Choroideremia Treatment Market, By Luxturna, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 194: Middle East and Africa Choroideremia Treatment Market, By Online Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 195: Middle East and Africa Choroideremia Treatment Market, By Hospital Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 196: Middle East and Africa Choroideremia Treatment Market, By Retail Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 197: Middle East and Africa Choroideremia Treatment Market, By Drugstores, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 198: Middle East and Africa Choroideremia Treatment Market, By Oral & Intravenous, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 199: Middle East and Africa Choroideremia Treatment Market, By Ophthalmic, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 200: GCC Choroideremia Treatment Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 201: GCC Choroideremia Treatment Market Value, By Route of Administration, 2023 (USD Billion)
Figure 202: GCC Choroideremia Treatment Market Share, By Treatment Type, By Value, 2023 (%)
Figure 203: GCC Choroideremia Treatment Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 204: GCC Choroideremia Treatment Market Share, By Route of Administration, By Value, 2023 (%)
Figure 205: Israel Choroideremia Treatment Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 206: Israel Choroideremia Treatment Market Value, By Route of Administration, 2023 (USD Billion)
Figure 207: Israel Choroideremia Treatment Market Share, By Treatment Type, By Value, 2023 (%)
Figure 208: Israel Choroideremia Treatment Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 209: Israel Choroideremia Treatment Market Share, By Route of Administration, By Value, 2023 (%)
Figure 210: South Africa Choroideremia Treatment Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 211: South Africa Choroideremia Treatment Market Value, By Route of Administration, 2023 (USD Billion)
Figure 212: South Africa Choroideremia Treatment Market Share, By Treatment Type, By Value, 2023 (%)
Figure 213: South Africa Choroideremia Treatment Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 214: South Africa Choroideremia Treatment Market Share, By Route of Administration, By Value, 2023 (%)
Figure 215: Rest of Middle East and Africa Choroideremia Treatment Market, By Value, 2020-2030 (USD Billion & CAGR)
Figure 216: Rest of Middle East and Africa Choroideremia Treatment Market Value, By Route of Administration, 2023 (USD Billion)
Figure 217: Rest of Middle East and Africa Choroideremia Treatment Market Share, By Treatment Type, By Value, 2023 (%)
Figure 218: Rest of Middle East and Africa Choroideremia Treatment Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 219: Rest of Middle East and Africa Choroideremia Treatment Market Share, By Route of Administration, By Value, 2023 (%)
Figure 220: Market Share of Prominent Companies of Global Choroideremia Treatment Market, 2023 (%)
List of Tables
Table A1: Global Impact of Macro Economic Factors, By Region
Table A2: United States Choroideremia Treatment Market, By Treatment Type, By Value, 2020-2023 (USD Billion)
Table A3: United States Choroideremia Treatment Market, By Treatment Type, By Value, 2024-2030 (USD Billion)
Table A4: United States Choroideremia Treatment Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A5: United States Choroideremia Treatment Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A6: United States Choroideremia Treatment Market, By Route of Administration, By Value, 2020-2023 (USD Billion)
Table A7: United States Choroideremia Treatment Market, By Route of Administration, By Value, 2024-2030 (USD Billion)
Table A8: Canada Choroideremia Treatment Market, By Treatment Type, By Value, 2020-2023 (USD Billion)
Table A9: Canada Choroideremia Treatment Market, By Treatment Type, By Value, 2024- 2030 (USD Billion)
Table A10: Canada Choroideremia Treatment Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A11: Canada Choroideremia Treatment Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A12: Canada Choroideremia Treatment Market, By Route of Administration, By Value, 2020-2023 (USD Billion)
Table A13: Canada Choroideremia Treatment Market, By Route of Administration, By Value, 2024-2030 (USD Billion)
Table A14: Brazil Choroideremia Treatment Market, By Treatment Type, By Value, 2020-2023 (USD Billion)
Table A15: Brazil Choroideremia Treatment Market, By Treatment Type, By Value, 2024-2030 (USD Billion)
Table A16: Brazil Choroideremia Treatment Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A17: Brazil Choroideremia Treatment Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A18: Brazil Choroideremia Treatment Market, By Route of Administration, By Value, 2020-2023 (USD Billion)
Table A19: Brazil Choroideremia Treatment Market, By Route of Administration, By Value, 2024-2030 (USD Billion)
Table A20: Mexico Choroideremia Treatment Market, By Treatment Type, By Value, 2020-2023 (USD Billion)
Table A21: Mexico Choroideremia Treatment Market, By Treatment Type, By Value, 2024-2030 (USD Billion)
Table A22: Mexico Choroideremia Treatment Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A23: Mexico Choroideremia Treatment Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A24: Mexico Choroideremia Treatment Market, By Route of Administration, By Value, 2020-2023 (USD Billion)
Table A25: Mexico Choroideremia Treatment Market, By Route of Administration, By Value, 2024-2030 (USD Billion)
Table A26: Rest of Americas Choroideremia Treatment Market, By Treatment Type, By Value, 2020-2023 (USD Billion)
Table A27: Rest of Americas Choroideremia Treatment Market, By Treatment Type, By Value, 2024-2030 (USD Billion)
Table A28: Rest of Americas Choroideremia Treatment Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A29: Rest of Americas Choroideremia Treatment Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A30: Rest of Americas Choroideremia Treatment Market, By Route of Administration, By Value, 2020-2023 (USD Billion)
Table A31: Rest of Americas Choroideremia Treatment Market, By Route of Administration, By Value, 2024-2030 (USD Billion)
Table A32: Russia Choroideremia Treatment Market, By Treatment Type, By Value, 2020-2023 (USD Billion)
Table A33: Russia Choroideremia Treatment Market, By Treatment Type, By Value, 2024-2030 (USD Billion)
Table A34: Russia Choroideremia Treatment Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A35: Russia Choroideremia Treatment Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A36: Russia Choroideremia Treatment Market, By Route of Administration, By Value, 2020-2023 (USD Billion)
Table A37: Russia Choroideremia Treatment Market, By Route of Administration, By Value, 2024-2030 (USD Billion)
Table A38: France Choroideremia Treatment Market, By Treatment Type, By Value, 2020-2023 (USD Billion)
Table A39: France Choroideremia Treatment Market, By Treatment Type, By Value, 2024-2030 (USD Billion)
Table A40: France Choroideremia Treatment Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A41: France Choroideremia Treatment Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A42: France Choroideremia Treatment Market, By Route of Administration, By Value, 2020-2023 (USD Billion)
Table A43: France Choroideremia Treatment Market, By Route of Administration, By Value, 2024-2030 (USD Billion)
Table A44: United Kingdom Choroideremia Treatment Market, By Treatment Type, By Value, 2020-2023 (USD Billion)
Table A45: United Kingdom Choroideremia Treatment Market, By Treatment Type, By Value, 2024-2030 (USD Billion)
Table A46: United Kingdom Choroideremia Treatment Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A47: United Kingdom Choroideremia Treatment Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A48: United Kingdom Choroideremia Treatment Market, By Route of Administration, By Value, 2020-2023 (USD Billion)
Table A49: United Kingdom Choroideremia Treatment Market, By Route of Administration, By Value, 2024-2030 (USD Billion)
Table A50: Germany Choroideremia Treatment Market, By Treatment Type, By Value, 2020-2023 (USD Billion)
Table A51: Germany Choroideremia Treatment Market, By Treatment Type, By Value, 2024-2030 (USD Billion)
Table A52: Germany Choroideremia Treatment Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A53: Germany Choroideremia Treatment Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A54: Germany Choroideremia Treatment Market, By Route of Administration, By Value, 2020-2023 (USD Billion)
Table A55: Germany Choroideremia Treatment Market, By Route of Administration, By Value, 2024-2030 (USD Billion)
Table A56: Italy Choroideremia Treatment Market, By Treatment Type, By Value, 2020-2023 (USD Billion)
Table A57: Italy Choroideremia Treatment Market, By Treatment Type, By Value, 2024-2030 (USD Billion)
Table A58: Italy Choroideremia Treatment Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A59: Italy Choroideremia Treatment Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A60: Italy Choroideremia Treatment Market, By Route of Administration, By Value, 2020-2023 (USD Billion)
Table A61: Italy Choroideremia Treatment Market, By Route of Administration, By Value, 2024-2030 (USD Billion)
Table A62: Spain Choroideremia Treatment Market, By Treatment Type, By Value, 2020-2023 (USD Billion)
Table A63: Spain Choroideremia Treatment Market, By Treatment Type, By Value, 2024-2030 (USD Billion)
Table A64: Spain Choroideremia Treatment Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A65: Spain Choroideremia Treatment Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A66: Spain Choroideremia Treatment Market, By Route of Administration, By Value, 2020-2023 (USD Billion)
Table A67: Spain Choroideremia Treatment Market, By Route of Administration, By Value, 2024-2030 (USD Billion)
Table A68: Turkey Choroideremia Treatment Market, By Treatment Type, By Value, 2020-2023 (USD Billion)
Table A69: Turkey Choroideremia Treatment Market, By Treatment Type, By Value, 2024-2030 (USD Billion)
Table A70: Turkey Choroideremia Treatment Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A71: Turkey Choroideremia Treatment Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A72: Turkey Choroideremia Treatment Market, By Route of Administration, By Value, 2020-2023 (USD Billion)
Table A73: Turkey Choroideremia Treatment Market, By Route of Administration, By Value, 2024-2030 (USD Billion)
Table A74: Rest of Europe Choroideremia Treatment Market, By Treatment Type, By Value, 2020-2023 (USD Billion)
Table A75: Rest of Europe Choroideremia Treatment Market, By Treatment Type, By Value, 2024-2030 (USD Billion)
Table A76: Rest of Europe Choroideremia Treatment Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A77: Rest of Europe Choroideremia Treatment Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A78: Rest of Europe Choroideremia Treatment Market, By Route of Administration, By Value, 2020-2023 (USD Billion)
Table A79: Rest of Europe Choroideremia Treatment Market, By Route of Administration, By Value, 2024-2030 (USD Billion)
Table A80: China Choroideremia Treatment Market, By Treatment Type, By Value, 2020-2023 (USD Billion)
Table A81: China Choroideremia Treatment Market, By Treatment Type, By Value, 2024-2030 (USD Billion)
Table A82: China Choroideremia Treatment Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A83: China Choroideremia Treatment Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A84: China Choroideremia Treatment Market, By Route of Administration, By Value, 2020-2023 (USD Billion)
Table A85: China Choroideremia Treatment Market, By Route of Administration, By Value, 2024-2030 (USD Billion)
Table A86: India Choroideremia Treatment Market, By Treatment Type, By Value, 2020-2023 (USD Billion)
Table A87: India Choroideremia Treatment Market, By Treatment Type, By Value, 2024-2030 (USD Billion)
Table A88: India Choroideremia Treatment Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A89: India Choroideremia Treatment Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A90: India Choroideremia Treatment Market, By Route of Administration, By Value, 2020-2023 (USD Billion)
Table A91: India Choroideremia Treatment Market, By Route of Administration, By Value, 2024-2030 (USD Billion)
Table A92: South Korea Choroideremia Treatment Market, By Treatment Type, By Value, 2020-2023 (USD Billion)
Table A93: South Korea Choroideremia Treatment Market, By Treatment Type, By Value, 2024-2030 (USD Billion)
Table A94: South Korea Choroideremia Treatment Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A95: South Korea Choroideremia Treatment Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A96: South Korea Choroideremia Treatment Market, By Route of Administration, By Value, 2020-2023 (USD Billion)
Table A97: South Korea Choroideremia Treatment Market, By Route of Administration, By Value, 2024-2030 (USD Billion)
Table A98: Japan Choroideremia Treatment Market, By Treatment Type, By Value, 2020-2023 (USD Billion)
Table A99: Japan Choroideremia Treatment Market, By Treatment Type, By Value, 2024-2030 (USD Billion)
Table A100: Japan Choroideremia Treatment Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A101: Japan Choroideremia Treatment Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A102: Japan Choroideremia Treatment Market, By Route of Administration, By Value, 2020-2023 (USD Billion)
Table A103: Japan Choroideremia Treatment Market, By Route of Administration, By Value, 2024-2030 (USD Billion)
Table A104: Singapore Choroideremia Treatment Market, By Treatment Type, By Value, 2020-2023 (USD Billion)
Table A105: Singapore Choroideremia Treatment Market, By Treatment Type, By Value, 2024-2030 (USD Billion)
Table A106: Singapore Choroideremia Treatment Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A107: Singapore Choroideremia Treatment Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A108: Singapore Choroideremia Treatment Market, By Route of Administration, By Value, 2020-2023 (USD Billion)
Table A109: Singapore Choroideremia Treatment Market, By Route of Administration, By Value, 2024-2030 (USD Billion)
Table A110: Indonesia Choroideremia Treatment Market, By Treatment Type, By Value, 2020-2023 (USD Billion)
Table A111: Indonesia Choroideremia Treatment Market, By Treatment Type, By Value, 2024-2030 (USD Billion)
Table A112: Indonesia Choroideremia Treatment Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A113: Indonesia Choroideremia Treatment Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A114: Indonesia Choroideremia Treatment Market, By Route of Administration, By Value, 2020-2023 (USD Billion)
Table A115: Indonesia Choroideremia Treatment Market, By Route of Administration, By Value, 2024-2030 (USD Billion)
Table A116: Rest of Asia Pacific Choroideremia Treatment Market, By Treatment Type, By Value, 2020-2023 (USD Billion)
Table A117: Rest of Asia Pacific Choroideremia Treatment Market, By Treatment Type, By Value, 2024-2030 (USD Billion)
Table A118: Rest of Asia Pacific Choroideremia Treatment Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A119: Rest of Asia Pacific Choroideremia Treatment Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A120: Rest of Asia Pacific Choroideremia Treatment Market, By Route of Administration, By Value, 2020-2023 (USD Billion)
Table A121: Rest of Asia Pacific Choroideremia Treatment Market, By Route of Administration, By Value, 2024-2030 (USD Billion)
Table A122: GCC Choroideremia Treatment Market, By Treatment Type, By Value, 2020-2023 (USD Billion)
Table A123: GCC Choroideremia Treatment Market, By Treatment Type, By Value, 2024-2030 (USD Billion)
Table A124: GCC Choroideremia Treatment Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A125: GCC Choroideremia Treatment Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A126: GCC Choroideremia Treatment Market, By Route of Administration, By Value, 2020-2023 (USD Billion)
Table A127: GCC Choroideremia Treatment Market, By Route of Administration, By Value, 2024-2030 (USD Billion)
Table A128: Israel Choroideremia Treatment Market, By Treatment Type, By Value, 2020-2023 (USD Billion)
Table A129: Israel Choroideremia Treatment Market, By Treatment Type, By Value, 2024-2030 (USD Billion)
Table A130: Israel Choroideremia Treatment Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A131: Israel Choroideremia Treatment Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A132: Israel Choroideremia Treatment Market, By Route of Administration, By Value, 2020-2023 (USD Billion)
Table A133: Israel Choroideremia Treatment Market, By Route of Administration, By Value, 2024-2030 (USD Billion)
Table A134: South Africa Choroideremia Treatment Market, By Treatment Type, By Value, 2020-2023 (USD Billion)
Table A135: South Africa Choroideremia Treatment Market, By Treatment Type, By Value, 2024-2030 (USD Billion)
Table A136: South Africa Choroideremia Treatment Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A137: South Africa Choroideremia Treatment Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A138: South Africa Choroideremia Treatment Market, By Route of Administration, By Value, 2020-2023 (USD Billion)
Table A139: South Africa Choroideremia Treatment Market, By Route of Administration, By Value, 2024-2030 (USD Billion)
Table A140: Rest of Middle East and Africa Choroideremia Treatment Market, By Treatment Type, By Value, 2020-2023 (USD Billion)
Table A141: Rest of Middle East and Africa Choroideremia Treatment Market, By Treatment Type, By Value, 2024-2030 (USD Billion)
Table A142: Rest of Middle East and Africa Choroideremia Treatment Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
Table A143: Rest of Middle East and Africa Choroideremia Treatment Market, By Distribution Channel, By Value, 2024-2030 (USD Billion)
Table A144: Rest of Middle East and Africa Choroideremia Treatment Market, By Route of Administration, By Value, 2020-2023 (USD Billion)
Table A145: Rest of Middle East and Africa Choroideremia Treatment Market, By Route of Administration, By Value, 2024-2030 (USD Billion)

Companies Mentioned

  • F. Hoffmann-La Roche Ltd
  • Retina Implant AG
  • 4D Molecular Therapeutics
  • Biogen
  • Spark Therapeutics, Inc.
  • Copernicus Therapeutics, Inc.
  • Novartis AG
  • bluebird bio, Inc.
  • Wize Pharma Inc.
  • Pixium Vision

Related Topics

Related Reports

Choroideremia - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Choroideremia - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Choroideremia - Pipeline Insight, 2024 - Product Image

Choroideremia - Pipeline Insight, 2024

  • Clinical Trials
  • 60 Pages
  • Global
From
Choroideremia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Choroideremia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 133 Pages
  • Global
From
Ophthalmics Collaboration and Licensing Deals 2019-2024 - Product Image

Ophthalmics Collaboration and Licensing Deals 2019-2024

  • Report
  • 200 Pages
  • Global
From
Acute Ocular Pain Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Source of Pain, Treatment Type, Sales Channel, Region, By Country: 2020-2030 - Product Image

Acute Ocular Pain Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Source of Pain, Treatment Type, Sales Channel, Region, By Country: 2020-2030

  • Report
  • 322 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.